Therapeutics

LU25-109

Tools

Back to the Top

Overview

Name: LU25-109
Therapy Type: Small Molecule (timeline)
Target Type: Cholinergic System (timeline)
Condition(s): Alzheimer's Disease
U.S. FDA Status: Alzheimer's Disease (Discontinued)
Approved for: None

Background

LU25-109 is a selective partial M1 agonist and an M2/M3 antagonist.

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

No Available Comments

References

No Available References

Further Reading

No Available Further Reading